4,4,5,5-Tetramethyl-2-(2-methyl-5-propylthiophen-3-yl)-1,3,2-dioxaborolane

Catalog No. :
ACELBL458
CAS No. :
2223031-62-5
Molecular Formula :
C14H23BO2S
Molecular Weight :
266.21

IUPAC Name:4,4,5,5-tetramethyl-2-(2-methyl-5-propylthiophen-3-yl)-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-(2-methyl-5-propylthiophen-3-yl)-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4,5,5-Tetramethyl-2-(2-methyl-5-propylthiophen-3-yl)-1,3,2-dioxaborolane
IUPAC Name4,4,5,5-tetramethyl-2-(2-methyl-5-propylthiophen-3-yl)-1,3,2-dioxaborolane
Molecular FormulaC14H23BO2S
Molecular Weight266.21
SMILESCCCC1=CC(B2OC(C)(C)C(C)(C)O2)=C(C)S1
InChI KeySYJZMFIOICYZJH-UHFFFAOYSA-N
Synonym2-Methyl-5-(n-propyl)thiophene-3-boronic acid pinacol ester;4,4,5,5-Tetramethyl-2-(2-methyl-5-propyl-3-thienyl)-1,3,2-dioxaborolane;1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-(2-methyl-5-propyl-3-thienyl)-
CAS No.2223031-62-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACELBL458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACELBL458 route product structure diagram
    ACELBL4582223031-62-5
Inquiry

2. ACELBL458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACELBL458 route product structure diagram
    ACELBL4582223031-62-5
Inquiry

Comments (0)